Inventor · disambiguated record
Juha Punnonen
Also filed as: PUNNONEN JUHA
30 granted patents·22 pending applications·478 citations·filing 1999–2025
97Inventor score
Files withMAXYGEN INC21KARRER ERIK E7MAXYGEN INC A DELAWARE CORP4APT DORIS3ASCENDIS PHARMA ONCOLOGY DIV A/S3
Top patents by PatentIndex Score
52 records- 0196US6541011B2Antigen library immunizationMAXYGEN INC·Filed 1999·Granted Apr 1, 2003·152 cites·47 claims
- 0295US8715694B2Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E proteinAPT DORIS·Filed 2012·Granted May 6, 2014·50 cites·15 claims
- 0394US7794718B2Immunosuppressive polypeptides and nucleic acidsPERSEID THERAPEUTICS LLC·Filed 2008·Granted Sep 14, 2010·38 cites·19 claims
- 0493US10544222B2PD1/CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Jan 28, 2020·22 cites·15 claims
- 0593US10501542B2CTLA4 bindersMERCK SHARP & DOHME·Filed 2016·Granted Dec 10, 2019·16 cites·15 claims
- 0693US8071095B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2010·Granted Dec 6, 2011·17 cites·19 claims
- 0792US6569435B1Flavivirus and alphavirus recombinant antigen librariesMAXYGEN INC·Filed 2000·Granted May 27, 2003·31 cites·51 claims
- 0891US7094875B2Co-stimulatory polypeptidesMAXYGEN INC·Filed 2001·Granted Aug 22, 2006·24 cites·53 claims
- 0991US6576757B1Polynucleotides encoding flavivirus and alphavirus multivalent antigenic polypeptidesMAXYGEN INC·Filed 2000·Granted Jun 10, 2003·25 cites·54 claims
- 1090US8318176B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Nov 27, 2012·10 cites·8 claims
- 1190US8283447B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Oct 9, 2012·10 cites·8 claims
- 1290US8268587B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Sep 18, 2012·10 cites·48 claims
- 1390US7612170B2Co-stimulatory polypeptidesMAXYGEN INC·Filed 2006·Granted Nov 3, 2009·16 cites·21 claims
- 1487US8496935B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Jul 30, 2013·7 cites·27 claims
- 1587US8445230B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted May 21, 2013·7 cites·48 claims
- 1686US8491899B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Jul 23, 2013·6 cites·21 claims
- 1786US8158131B2Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E proteinAPT DORIS·Filed 2008·Granted Apr 17, 2012·7 cites·12 claims
- 1879US11649290B2CTLA4 bindersMERCK SHARP & DOHME LLC·Filed 2019·Granted May 16, 2023·1 cites·14 claims
- 1979US7786159B2Thrombopoietin mimeticsSTATEGICS INC·Filed 2007·Granted Aug 31, 2010·4 cites·12 claims
- 2077US8168772B2Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shufflingAPT DORIS·Filed 2007·Granted May 1, 2012·2 cites·22 claims
- 2177US7476390B2Flavivirus antigensMAXYGEN INC·Filed 2003·Granted Jan 13, 2009·7 cites·14 claims
- 2274US7183376B2Variant B7 co-stimulatory moleculesMAXYGEN INC·Filed 2001·Granted Feb 27, 2007·6 cites·30 claims
- 2374US7074590B2Chimeric promotersMAXYGEN INC·Filed 2001·Granted Jul 11, 2006·5 cites·46 claims
- 2470US2007087374A1Optimization of immunomodulatory properties of genetic vaccinesMAXYGEN INC·Filed 2006·Application pending·0 cites
- 2570US2007087373A1Optimization of immunomodulatory properties of genetic vaccinesMAXYGEN INC·Filed 2006·Application pending·0 cites
- 2668US9163027B2Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survivalSTATEGICS INC·Filed 2013·Granted Oct 20, 2015·2 cites·43 claims
- 2768US8143287B2Thrombopoietin mimeticsSPENCER JEFFREY R·Filed 2010·Granted Mar 27, 2012·2 cites·46 claims
- 2867US2005222069A1Optimization of immunomodulatory properties of genetic vaccinesMAXYGEN INC·Filed 2004·Application pending·0 cites
- 2967US2006045888A1Antigen library immunizationMAXYGEN INC·Filed 2004·Application pending·0 cites
- 3066US2005064464A1Optimization of immunomodulatory properties of genetic vaccinesMAXYGEN INC A DELAWARE CORP·Filed 2004·Application pending·0 cites
- 3166US2005164222A1Optimization of immunomodulatory properties of genetic vaccinesMAXYGEN INC A DELAWARE CORP·Filed 2004·Application pending·0 cites
- 3264US2010261660A1Novel co-stimulatory moleculesMAXYGEN INC·Filed 2006·Application pending·0 cites
- 3363US9657024B2Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survivalSTATEGICS INC·Filed 2013·Granted May 23, 2017·1 cites·36 claims
- 3462US9186397B2Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E proteinALTRAVAX INC·Filed 2014·Granted Nov 17, 2015·0 cites·15 claims
- 3562US2004001849A1Antigen library immunizationMAXYGEN INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
- 3662US2005123522A1Monocyte-derived dendritic cell subsetsMAXYGEN INC·Filed 2004·Application pending·0 cites
- 3761US2005260605A1Targeting of genetic vaccine vectorsMAXYGEN INC·Filed 2004·Application pending·0 cites
- 3860US2025289890A1Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agentsMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 3957US7390619B1Optimization of immunomodulatory properties of genetic vaccinesMAXYGEN INC·Filed 2000·Granted Jun 24, 2008·0 cites·4 claims
- 4056US7115712B1Cytokine polypeptidesMAXYGEN INC·Filed 2000·Granted Oct 3, 2006·0 cites·12 claims
- 4156US2008019988A1Targeting of genetic vaccine vectorsMAXYGEN INC·Filed 2007·Application pending·0 cites
- 4254US2006264615A1Cytokine polypeptides and nucleic acidsMAXYGEN INC·Filed 2006·Application pending·0 cites
- 4353US2016151478A1Novel Flavivirus AntigensALTRAVAX INC·Filed 2015·Application pending·0 cites
- 4453US2005084913A1Novel tumor-associated antigensMAXYGEN INC·Filed 2004·Application pending·0 cites
- 4552US12358986B2Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocking agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 15, 2025·0 cites·5 claims
- 4652US2001026937A1Monocyte-derived dendritic cell subsetsFiled 2001·Application pending·0 cites
- 4748US2004110295A1Nucleic acid vectorsMAXYGEN INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
- 4848US2005154189A1Novel co-stimulatory moleculesMAXYGEN INC·Filed 2002·Application pending·0 cites
- 4945US2022054476A1Sustained local drug levels for innate immune agonistsASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
- 5045US2022054478A1Minimization of systemic inflammationASCENDIS PHARMA ONCOLOGY DIV A/S·Filed 2020·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →